Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
1.700
+0.040 (2.41%)
At close: Dec 20, 2024, 4:00 PM
1.750
+0.050 (2.94%)
After-hours: Dec 20, 2024, 7:05 PM EST
Vigil Neuroscience Market Cap
Vigil Neuroscience has a market cap or net worth of $69.42 million as of December 20, 2024. Its market cap has decreased by -43.92% in one year.
Market Cap
69.42M
Enterprise Value
-28.67M
1-Year Change
-43.92%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on January 7, 2022, Vigil Neuroscience's market cap has decreased from $395.70M to $69.42M, a decrease of -82.46%. That is a compound annual growth rate of -44.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 69.42M | -42.76% |
| Dec 29, 2023 | 121.27M | -72.73% |
| Dec 30, 2022 | 444.76M | 12.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 70.56M |
| Oncolytics Biotech | 70.34M |
| Vivani Medical | 69.90M |
| Vistagen Therapeutics | 69.61M |
| Prenetics Global | 68.97M |
| Burning Rock Biotech | 67.50M |
| Rockwell Medical | 67.22M |
| Agenus | 66.39M |